Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach symbols : LIFE save search
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 1.05%
H: 1.04%
C: -0.52%
atyr2810 pharma treatment tumor research preclinical meeting therapy growth
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Sarcoidosis and Transitioning from Steroids to New and Investigational Therapies
Published: 2023-03-20 (Crawled : 14:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 4.26%
H: 1.62%
C: -2.04%
pharma research meeting
aTyr Pharma to Present New Data on the Mechanism of Action of Efzofitimod at the American Thoracic Society 2023 International Conference
Published: 2023-01-31 (Crawled : 16:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.44%
H: 3.1%
C: 1.77%
pharma conference international
aTyr Pharma Gains E.U. Patent Covering Use of Efzofitimod with Pirfenidone for Lung Inflammation or Fibrosis
Published: 2023-01-19 (Crawled : 16:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.0%
H: 2.68%
C: 1.78%
fibrosis lung pharma patent
European Commission Grants Orphan Drug Designation for aTyr Pharma’s Efzofitimod for Treatment of SarcoidosisGlobal pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis launched in Europe
Published: 2023-01-18 (Crawled : 18:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.0%
H: 2.45%
C: -2.18%
treatment europe designation drug grants study
aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment
Published: 2022-12-15 (Crawled : 21:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.81%
pharma
aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
Published: 2022-09-27 (Crawled : 13:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 2.83%
H: 0.0%
C: -4.12%
pharma study
aTyr Pharma to Present Poster at the European Respiratory Society (ERS) International Congress 2022
Published: 2022-09-01 (Crawled : 17:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.22%
pharma respiratory international
aTyr Pharma Announces Second Quarter 2022 Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -1.13%
H: 4.57%
C: 4.0%
pharma update results
aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
Published: 2022-05-17 (Crawled : 13:20) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 2.27%
H: 3.81%
C: 1.59%
atyr1923 pharma conference international
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic SclerosisSecond U.S. orphan drug designation for efzofitimod clinical program
Published: 2022-04-13 (Crawled : 17:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 0.21%
H: 10.73%
C: 7.16%
atyr1923 treatment fda pharma drug program designation
aTyr Pharma to Present Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference
Published: 2022-04-01 (Crawled : 20:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 4.67%
H: 6.61%
C: -0.18%
atyr1923 pharma conference international
aTyr Pharma to Present at Upcoming Investor Conferences in March
Published: 2022-03-03 (Crawled : 00:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
conference pharma
aTyr Pharma Announces FDA Orphan Drug Designation for ATYR1923 for Treatment of SarcoidosisCompany expects to initiate registrational trial of ATYR1923 in pulmonary sarcoidosis in 2022
Published: 2022-01-06 (Crawled : 15:30) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -1.1%
H: 2.78%
C: -0.56%
atyr1923 treatment fda drug trial orphan drug designation
aTyr Pharma to Present at Antibody Engineering & Therapeutics ConferenceNovel engineering approach accelerates generation of new antibody candidates from tRNA synthetase platform.
Published: 2021-12-10 (Crawled : 15:02) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -4.24%
H: 0.0%
C: 0.0%
conference therapeutics antibody platform
aTyr Pharma and FUJIFILM Diosynth Biotechnologies Announce Manufacturing Agreement for aTyr’s Lead Therapeutic Candidate ATYR1923
Published: 2021-11-30 (Crawled : 15:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
biotech iot pharma
aTyr Pharma Presents Research Demonstrating Effects of Novel NRP2-Targeting Antibody, ATYR2810, on Tumor Associated Macrophages at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-11-09 (Crawled : 17:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -0.47%
H: 2.73%
C: 2.02%
immunotherapy therapy cancer antibody research
aTyr Pharma to Webcast Conference Call Reporting Third Quarter 2021 Financial ResultsManagement to host conference call and webcast on November 10th at 5:00 pm EST / 2:00 pm PST
Published: 2021-11-03 (Crawled : 19:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -0.68%
H: 6.21%
C: 1.26%
financial results results conference
aTyr Pharma Announces Pricing of $75 Million Public Offering of Common Stock
Published: 2021-09-16 (Crawled : 13:00) - biospace.com/
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: 8.72%
H: 23.72%
C: 10.76%
offering pharma
Otonomy Appoints Jill Broadfoot to Board of Directors
Published: 2021-08-19 (Crawled : 12:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: -14.69%
LIFE | $1.64 3.15% 160K
|
Health Technology
|
| O: -1.5%
H: 2.17%
C: -1.74%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.